![](/img/cover-not-exists.png)
Intensive first-line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: preliminary phase II data and prediction of individual limiting toxicity syndromes by pharmacogenomic biomarkers
Bruera, Gemma, Massacese, Silvia, Pepe, Francesco, Malapelle, Umberto, Dal Mas, Antonella, Ciacco, Eugenio, Calvisi, Giuseppe, Troncone, Giancarlo, Simmaco, Maurizio, Ricevuto, EnricoVolume:
11
Language:
english
Journal:
Therapeutic Advances in Medical Oncology
DOI:
10.1177/1758835919846421
Date:
January, 2019
File:
PDF, 180 KB
english, 2019